Thymalin
Thymaline / Thymic Peptide Extract
Thymalin (also known as Thymic Peptide Extract or Thymalin) is a polypeptide complex extracted from calf thymus glands, developed by Professors Vladimir Khavinson and Vyacheslav Morozov at the St. Petersburg Institute of Bioregulation and Gerontology as an immunomodulatory bioregulator. It was one of the earliest bioregulator peptides investigated for anti-aging applications, with research spanning over 40 years in Russian gerontological medicine. Thymalin is administered via intramuscular injection and targets restoration of thymic function and T-cell immunity that declines with age.
Mécanisme d'action
Bovine thymus extract containing a mixture of thymic peptide factors. Restores T-cell immunity, promotes thymic regeneration, and modulates immune system homeostasis. Part of the Khavinson bioregulator family targeting the thymus and immune system.
Protocoles de recherche
Pour des fins de recherche uniquement. Pas de conseil médical.
Khavinson protocols use 5-10mg intramuscularly daily for 5-10 day cycles, repeated every 6-12 months. Some protocols use sublingual or oral administration at 10-20mg daily.
Notes de recherche
Clinical Research Status
Thymalin has been studied in longitudinal clinical trials spanning over 15 years in elderly populations, with Khavinson's landmark study demonstrating a 46% reduction in mortality over a 12-year follow-up period in treated versus control groups. It is registered as a pharmaceutical preparation in Russia for immunodeficiency states and as an adjuvant in cancer treatment. While these results are remarkable, they have not been independently replicated in Western research settings or subjected to rigorous international peer review standards.
Key Published Findings
The most cited study showed that combined Thymalin and Epithalon treatment in elderly patients (60-80 years) reduced mortality, improved immune function, and normalized neuroendocrine regulation over 6-12 years of observation. Immunological research demonstrates restoration of T-cell subpopulation ratios, increased natural killer cell activity, and normalization of cytokine profiles in immunocompromised elderly patients. Animal studies in various species show increased lifespan, improved tumor resistance, and restoration of thymic architecture following Thymalin administration.
Safety Profile
Thymalin has been used clinically in Russia for decades with a well-established safety profile showing minimal adverse effects at standard therapeutic doses. The most commonly reported side effects are mild injection site reactions and occasional allergic responses in individuals sensitive to bovine-derived products. As an animal-derived extract, theoretical concerns about prion contamination exist, though no cases have been reported in the published literature.
Comparison to Related Compounds
Thymalin differs from synthetic thymic peptides like Thymosin Alpha-1 (Zadaxin) in that it is a complex mixture of multiple thymic peptides rather than a single defined molecule. Compared to the synthetic thymic dipeptide Thymogen (Glu-Trp), Thymalin contains a broader range of immunoactive components but has less molecular specificity. Thymalin's multi-component nature is considered both an advantage (multiple synergistic mechanisms) and a limitation (difficult to standardize and characterize) compared to single-peptide approaches.
Community Observations
Users in the longevity community often use Thymalin as part of seasonal immune optimization protocols, particularly during winter months or periods of high infection risk. Many combine it with Epithalon in what is sometimes called the "Khavinson protocol" for comprehensive anti-aging effects targeting both immune function and cellular longevity. The requirement for intramuscular injection and limited sourcing options outside Russia present practical barriers for many interested users.
Moitié de vie
~Variable (mixture)
Réconstitution
Sterile saline or bacteriostatic water for injection
Conservation
Lyophilisé
Refrigerate 2-8C.
Réconstitué
Use within 24 hours of reconstitution.
Statut légal aux États-Unis
Autres noms connus
Questions fréquentes
Qu'est-ce que Thymalin ?
Thymalin (also known as Thymic Peptide Extract or Thymalin) is a polypeptide complex extracted from calf thymus glands, developed by Professors Vladimir Khavinson and Vyacheslav Morozov at the St. Petersburg Institute of Bioregulation and Gerontology as an immunomodulatory bioregulator. It was one of the earliest bioregulator peptides investigated for anti-aging applications, with research spanning over 40 years in Russian gerontological medicine. Thymalin is administered via intramuscular injection and targets restoration of thymic function and T-cell immunity that declines with age.
Comment agit Thymalin ?
Bovine thymus extract containing a mixture of thymic peptide factors. Restores T-cell immunity, promotes thymic regeneration, and modulates immune system homeostasis. Part of the Khavinson bioregulator family targeting the thymus and immune system.
Quel est le statut réglementaire de Thymalin aux États-Unis ?
Research chemical (approved in Russia)
Quelle est la demi-vie de Thymalin ?
~Variable (mixture)
Sous quels autres noms Thymalin est-il connu ?
Thymaline, Thymic Peptide Extract
Peptide Contacts fournit des résumés basés sur la recherche à des fins d’information uniquement. Nous ne hébergeons, n’épandons ni ne recommandons les documents des fournisseurs. Toutes les certificats d'analyse, certificats GMP et communications du fournisseur doivent être demandés et vérifiés directement par l'acheteur. Rien sur cette plateforme ne constitue un avis juridique, médical ou professionnel. Les utilisateurs sont entièrement responsables de la vérification des informations du fournisseur et de l’assurance de la conformité avec toutes les lois locales, d'état et fédérales applicables avant l'achat de tout produit chimique de recherche. L'utilisation de cette plateforme constitue l'acceptation pleine et entière de la responsabilité personnelle.
Lire la déclaration complète